Cytochrome P450 enzymes are commonly thought to oxidize substrates via an iron(IV)-oxo porphyrin radical cation transient termed Compound I, but kinetic studies of P450 Compounds I are essentially non-existent. We report production of Compound I from cytochrome P450 119 (CYP119) in high conversion from the corresponding Compound II species at low temperatures in buffer mixtures containing 50% glycerol by photolysis with 365 nm light from a pulsed lamp. Compound I was studied as a reagent in oxidations of benzyl alcohol and its benzylic mono-and dideuterio isotopomers. Pseudo-first-order rate constants obtained at −50 °C with concentrations of substrates between 1.0 and 6.0 mM displayed saturation kinetics that gave binding constants for the substrate in the Compound I species (K bind ) and first-order rate constants for the oxidation reactions (k ox ). Representative results are K bind = 214 M −1 and k ox = 0.48 s −1 for oxidation of benzyl alcohol. For the dideuterated substrate C 6 H 5 CD 2 OH, kinetics were studied between −50 °C and −25 °C, and a van't Hoff plot for complexation and an Arrhenius plot for the oxidation reaction were constructed. The H/D kinetic isotope effects (KIEs) at −50 °C were resolved into a large primary KIE (P = 11.9) and a small, inverse secondary KIE (S = 0.96). Comparison of values extrapolated to 22 °C of both the rate constant for oxidation of C 6 H 5 CD 2 OH and the KIE for the non-deuterated and dideuterated substrates to values obtained previously in laser flash photolysis experiments suggested that tunneling could be a significant component of the total rate constant at −50 °C. Cytochrome P450 enzymes (P450s or CYPs) are heme-containing enzymes that are widely distributed in nature and catalyze a wide range of reactions including numerous oxidations. 1,2 In humans, P450s are the major oxidants of drugs, pro-drugs, and xenobiotics, [3][4][5] generating great interest from the pharmaceutical perspective in regard to toxicology and drug dosing. P450s also are of medicinal interest due to the relationships of P450 over-expression with cancer and other disease states. [6][7][8] The active oxidizing forms of P450 enzymes have not been detected under turnover conditions, but they are widely believed to be iron(IV)-oxo species with the porphyrin oxidized to a radical cation. 1,9 Such species, termed Compounds I, are analogous to known intermediates formed in other heme-containing enzymes, such as peroxidases and catalases, upon reaction of the enzymes with hydrogen peroxide. 10 Unlike peroxidases and catalases, P450s typically are activated by a sequence of reactions comprised of reduction of the enzyme to the ferrous state, oxygen binding, a second-reduction step, and protonation steps. Nonetheless, activations of men@uic.edu. a Current address: School of Pharmacy, Luzhou Medical College, Luzhou, Sichuan, China, 646000 Supporting Information Available: Detailed kinetic results, NMR spectra of BA-d 1 and BA-d 2 , mass spectra for BA isotopomers. This material is available fre...